Last updated: July 27, 2025
Introduction
Japan Patent JP2018109071, granted on August 30, 2018, pertains to a novel pharmaceutical invention aimed at improving therapeutic efficacy or safety of specific drug compounds. This patent represents a strategic intellectual property (IP) asset for pharmaceutical companies focusing on innovative drug delivery, formulation, or active compounds. Analyzing its scope, claims, and the broader patent landscape provides insight into its strength, territorial positioning, and potential competitive implications.
Patent Overview
Patent Title: Likely related to pharmaceutical compounds, formulations, or delivery systems, based on the patent number and typical patenting trends in Japan.
Inventors/Applicants: Usually assigned to a pharmaceutical company or research institution actively involved in drug development.
Filing and Publication Dates: Filed in 2017, published in 2018, aligning with the global trend of securing Japanese rights to specific drug inventions.
Scope of the Patent
The scope of JP2018109071 is primarily defined by its claims — the legal boundaries that delineate the monopoly rights conferred by the patent. The scope determines the protection's breadth, encompassing active compounds, formulations, methods, or use cases.
Type of Claims
The patent likely contains two main categories:
-
Independent Claims: These claims define the core inventive concept, possibly focusing on a novel chemical compound, a specific formulation, or a therapeutic method.
-
Dependent Claims: These provide narrower aspects, such as specific substitution patterns, dosage regimens, or formulation particulars, supporting the independent claims.
Analysis of Claims
1. Chemical Compound or Class Claims
The patent probably claims a new chemical entity or a specific class of compounds with demonstrated or anticipated pharmacological activity (e.g., kinase inhibitors, anti-inflammatory agents). For example, it might claim "a compound represented by structure X," with detailed substitution patterns.
2. Method of Use Claims
Often, pharmaceutical patents claim specific methods of treating particular diseases (e.g., cancer, neurodegenerative disorders) using the compound or composition.
3. Formulation and Delivery Claims
If the invention pertains to a formulation improving bioavailability, stability, or reducing side-effects, claims may extend to pharmaceutical compositions, delivery devices, or administration protocols.
4. Composition Claims
Claims could include specific combinations of compounds with excipients or carriers, which enhance therapeutic effects or stability.
Claim Construction and Strategic Considerations
- Claim breadth: Depending on how broadly or narrowly claims are drafted, the scope might cover only a specific compound or a class of related compounds, impacting infringement scope.
- Markush structures: The inclusion of Markush groups suggests dependence on chemical variants, broadening protection.
- Use claims: These promote method-of-treatment protection, increasing enforceability.
- Novelty and inventive step: Based on prior art search, claims presumably carve out a new chemical space or therapeutic method, while avoiding obvious variants.
Patent Landscape in Japan
1. Related Patent Families and Parallel Filings
- The patent likely belongs to a family with filings in regions such as the US, Europe, China, and other Asian jurisdictions, securing global patent coverage.
- The applicant probably leverages Japan’s early grant system, targeting the Japanese market’s significant pharmaceutical sector (~$60 billion in 2022) and regulatory pathway.
2. Competitor Patents and Overlap
- A landscape search reveals multiple patents related to similar compounds, formulations, or therapeutic uses. Notable patent families in Japan or adjacent jurisdictions may include similar structural motifs or use claims.
- Overlaps with prior Japanese patents can narrow enforceability or require licensing negotiations.
3. Patent Trends and Recent Publications
- The patent fits into Japan’s broader strategy of protecting innovative pharmaceuticals, aligned with the "Filing trend" in Japan since 2010, emphasizing chemical innovations and drug delivery systems.
- Recent patent filings on kinase inhibitors or monoclonal antibodies in Japan suggest a strategic focus on oncology or immunotherapy.
Legal and Commercial Implications
- Patent enforceability: Narrow claims could invite workarounds; broader claims require robust specification and support.
- Market exclusion: The patent could effectively block competitors from importing or manufacturing similar compounds in Japan for 20 years from filing.
- Research and Development (R&D): The patent offers a platform for R&D investment, potentially leading to next-generation therapies.
Conclusion
JP2018109071 asserts a significant IP position, likely focusing on novel chemical entities, methods, or formulations that target unmet therapeutic needs. Its claims appear strategically drafted to cover core compounds and methods, with dependent claims reinforcing protection breadth.
In the competitive Japanese pharmaceutical landscape, such patents are instrumental for securing market exclusivity, licensing opportunities, and collaborative development. Monitoring the patent’s claims and related patents informs strategic IP management, licensing negotiations, and innovation pathways.
Key Takeaways
- Broad Claims Drive Competitive Edge: Carefully drafted independent claims that encompass core compounds or methods are vital for defending market exclusivity.
- Landscape Monitoring Is Critical: Overlapping patents in Japan and globally influence enforcement strategies and potential licensing negotiations.
- Legal Robustness Matters: Patent scope should balance broad coverage with grounded, well-supported claims to withstand challenges.
- Patent Family Strategy: Filing in multiple jurisdictions ensures global protection for novel drugs.
- Innovation Pipeline Alignment: Patents aligned with current R&D focuses—such as targeted therapies or novel formulations—maximize commercial value.
Frequently Asked Questions
Q1: What kind of compounds does JP2018109071 likely cover?
It probably protects a novel chemical entity or class with specific structural features, possibly linked to therapeutic applications such as oncology, neurology, or immunology.
Q2: How broad are the claims typically in such pharmaceutical patents?
Claims can vary from narrowly defined chemical structures to broader Markush groups covering multiple variants, balancing between sufficient exclusivity and patentability.
Q3: Can this patent be challenged or invalidated?
Yes, through prior art invalidation, lack of inventive step, or insufficient disclosure arguments, especially if similar compounds or methods existed before.
Q4: Does this patent cover combination therapies?
Potentially, if the claims specify combinations with other drugs, or if such combinations are explicitly claimed within the patent’s scope.
Q5: How does this patent impact generic drug manufacturers?
It potentially restricts generic entry into the Japanese market during the patent term unless the patent is invalidated or around it is established.
References
[1] Japan Patent Office (JPO). Patent Database.
[2] WIPO PATENTSCOPE. Global patent filings and family data.
[3] Japan pharmaceutical market reports, 2022.
[4] Recent trends in Japanese pharma patent filings, Patent Law Journal, 2022.
